共 10 条
- [1] Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors[J]. LUNG CANCER, 2011, 73 (01) : 96 - 102Brevet, MarieJohnson, Melissa L.Azzoli, Christopher G.Ladanyi, Marc
- [2] Epidermal Growth Factor Receptor Mutation Status in Circulating Free DNA in Serum From IPASS, a Phase III Study of Gefitinib or Carboplatin/Paclitaxel in Non-small Cell Lung Cancer[J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (01) : 115 - 121Goto, KoichiIchinose, YukitoOhe, YuichiroYamamoto, NobuyukiNegoro, ShunichiNishio, KazutoItoh, YohjiJiang, HaiyiDuffield, EmmaMcCormack, RoseSaijo, NagahiroMok, TonyFukuoka, Masahiro
- [3] Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer[J]. CLINICAL CANCER RESEARCH, 2006, 12 (13) : 3915 - 3921Kimura, HideharuKasahara, KazuoKawaishi, MakotoKunitoh, HideoTamura, TomohideHolloway, BrianNishio, Kazuto
- [4] Detection of mutations in EGFR in circulating lung-cancer cells[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (04) : 366 - 377Maheswaran, ShyamalaSequist, Lecia V.Nagrath, SunithaUlkus, LindseyBrannigan, BrianCollura, Chey V.Inserra, ElizabethDiederichs, SvenIafrate, A. JohnBell, Daphne W.Digumarthy, SubbaMuzikansky, AlonaIrimia, DanielSettleman, JeffreyTompkins, Ronald G.Lynch, Thomas J.Toner, MehmetHaber, Daniel A.
- [5] Ultrasensitive Measurement of Hotspot Mutations in Tumor DNA in Blood Using Error-Suppressed Multiplexed Deep Sequencing[J]. CANCER RESEARCH, 2012, 72 (14) : 3492 - 3498Narayan, AzeetCarriero, Nicholas J.Gettinger, Scott N.Kluytenaar, JeannieKozak, Kevin R.Yock, Torunn I.Muscato, Nicole E.Ugarelli, PedroDecker, Roy H.Patel, Abhijit A.
- [6] Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non-Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib[J]. CLINICAL CANCER RESEARCH, 2012, 18 (08) : 2391 - 2401Punnoose, Elizabeth A.Atwal, SiminderLiu, WeiqunRaja, RajivFine, Bernard M.Hughes, Brett G. M.Hicks, Rodney J.Hampton, Garret M.Amler, Lukas C.Pirzkall, AndreaLackner, Mark R.
- [7] Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial[J]. LANCET ONCOLOGY, 2012, 13 (03) : 239 - 246Rosell, RafaelCarcereny, EnricGervais, RadjVergnenegre, AlainMassuti, BartomeuFelip, EnriquetaPalmero, RamonGarcia-Gomez, RamonPallares, CintaMiguel Sanchez, JosePorta, RutCobo, ManuelGarrido, PilarLongo, FlaviaMoran, TeresaInsa, AmeliaDe Marinis, FilippoCorre, RomainBover, IsabelIlliano, AlfonsoDansin, Ericde Castro, JavierMilella, MicheleReguart, NoemiAltavilla, GiuseppeJimenez, UlpianoProvencio, MarianoAngel Moreno, MiguelTerrasa, JosefaMunoz-Langa, JoseValdivia, JavierIsla, DoloresDomine, ManuelMolinier, OlivierMazieres, JulienBaize, NathalieGarcia-Campelo, RosarioRobinet, GillesRodriguez-Abreu, DelvysLopez-Vivanco, GuillermoGebbia, VittorioFerrera-Delgado, LiobaBombaron, PierreBernabe, ReyesBearz, AlessandraArtal, AngelCortesi, EnricoRolfo, ChristianSanchez-Ronco, MariaDrozdowskyj, Ana
- [8] Cell-free nucleic acids as biomarkers in cancer patients[J]. NATURE REVIEWS CANCER, 2011, 11 (06) : 426 - 437Schwarzenbach, HeidiHoon, Dave S. B.Pantel, Klaus
- [9] Quantitative Detection of EGFR Mutations in Circulating Tumor DNA Derived from Lung Adenocarcinomas[J]. CLINICAL CANCER RESEARCH, 2011, 17 (24) : 7808 - 7815Taniguchi, KazuyaUchida, JunjiNishino, KazumiKumagai, ToruOkuyama, TakakoOkami, JiroHigashiyama, MasahikoKodama, KenImamura, FumioKato, Kikuya
- [10] Single-Molecule Detection of Epidermal Growth Factor Receptor Mutations in Plasma by Microfluidics Digital PCR in Non-Small Cell Lung Cancer Patients[J]. CLINICAL CANCER RESEARCH, 2009, 15 (06) : 2076 - 2084Yung, Tony K. F.Chan, K. C. AllenMok, Tony S. K.Tong, JoannaTo, Ka-FaiLo, Y. M. Dennis